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Abstract
Background:  Developments in information technology promise to revolutionise the delivery of
health care by providing access to data in a timely and efficient way. Information technology also
raises several important concerns about the confidentiality and privacy of health data. New and
existing legislation in Europe and North America may make access to patient level data difficult with
consequent impact on research and health surveillance. Although research is being conducted on
technical solutions  to protect  the  privacy  of  personal  health information, there  is  very  little
research on ways to improve individuals power over their health information. This paper proposes
a health care information directive, analogous to an advance directive, to facilitate choices regarding
health information disclosure.
Results and Discussion:  A health care information directive is described which creates a
decision matrix that combines the ethical appropriateness of the use of personal health information
with the sensitivity of the data. It creates a range of possibilities with in which individuals can choose
to contribute health information with or without consent, or not to contribute information at all.
Conclusion:  The health care information directive may increase individuals understanding of the
uses of health information and increase their willingness to contribute certain kinds of health
information. Further refinement and evaluation of the directive is required.
Introduction
As health care enters the 21st Century, information tech-
nology (IT) is assuming greater importance for clinical
care and health delivery systems. IT promises rapid ac-
cess to the health information required for clinical deci-
sions and management of the health care system, leading
to improved health outcomes and more efficient use of
resources. Efforts to integrate information technology
into health care continue to rise at a rapid rate. In many
settings and for many types of services, such information
systems are indispensable for health care.
The widespread dissemination of information technolo-
gy raises several problems. While one of the most herald-
ed areas of health information technology is the
electronic patient record, they also draw the most con-
cern [1]. Since medical records are highly personal, many
fear loss of confidentiality and privacy [2]. Fair informa-
tion principles, ethical codes and studies of patient's
preferences all support the importance of preserving
confidentiality and privacy [3–5].
The uses of health information extend beyond the clini-
cal domain [6]. Health services research, disease regis-
tries, and population epidemiology rely on data collected
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and archived in administrative databases. Such data res-
ervoirs can be linked and are a rich source of knowledge
on patterns of health care. The advent of electronic
health records could greatly enhance the quality, availa-
bility and timeliness of such data sources. Studies based
on these records are integral for providing feedback to
clinicians and administrators as well as to health care
consumers. For example, such studies form the basis of
initiatives, based on public demand, for greater account-
ability in the health care system through the use of report
cards.
While such initiatives require access to personal health
information, privacy protection initiatives have also be-
come part of public policy, hindering such efforts. Recent
legislative initiatives in Canada such as the federal gov-
ernment's Bill C-6 and the province of Ontario's Bill 159
promise to have an impact on the use of health informa-
tion for health administration, research and clinical care.
In Minnesota, a change in the legislation concerning the
access to health records required health providers to no-
tify all patients in writing that records could be released
for research purposes and to obtain a written authoriza-
tion for the use of medical records for research [7]. In the
United Kingdom, the Data Protection Act of 1998 (as-
sumed force of law, March 2000) placed restrictions on
the processing of health information and enhanced pri-
vacy conditions [8]. Such initiatives are commendable in
that the privacy of individual information is of para-
mount importance.
These legislative initiatives, though, may have unfortu-
nate adverse consequences. Depending on the stringency
of the legislation, many research and audit functions
such as health services research and cancer registries
may be at risk. It is unclear how informed both the pop-
ulation and legislators are concerning the uses of health
information. The media has consistently emphasized the
Orwellian dimensions of large databases [9]. There is ev-
idence from the literature that strict consent laws can in-
troduce a potentially crippling authorization bias [10–
13]. Authorization bias occurs when patients who release
personal health information for health research differ
from those who do not in important characteristics rele-
vant to the interpretation of health data. Such a bias, ap-
plied at a population level results in an inaccurate
estimate of the health status of the population.
Recent articles have underlined the challenges of keep-
ing health records both accessible and private [14,15].
These studies have largely confined attention to systems
level interventions focused on technical methods of
health data protection. To our knowledge, little has been
done to develop tools to improve patient knowledge and
understanding of health information, its uses and the
manner in which it is protected. It is unclear how sys-
tems initiatives alone will increase patient understand-
ing of health information uses, or empower them in their
choices with respect to health information usage.
Innovative models, therefore, are required to meet the
demands of the information age. Research on patient de-
cision aids suggests that they improve knowledge, reduce
decisional conflict and stimulate patients to be more ac-
tive in decision-making [16]. We suggest that an inter-
vention analogous to a decision aid could be developed to
enable health consumers to more appropriately specify
the level of sharing they wish to have for their personal
health information. The advance directive, used in end of
life care, is a type of decision aid that can provide a tem-
plate for such an aid, which we propose to call a 'health
care information directive' [17].
Results
Table 1 shows the proposed health information directive.
The health information directive seeks to integrate sen-
sitivity of data with ethical validity of use. It presents the
permutations and combinations of sensitivity and usage
in a matrix that forms a table, similar to an advance di-
rective. The goal of the health information directive is to
allow individuals to make informed choices regarding
how their health information can be used. Currently,
models of consent for the use of health information de-
rive from consent for clinical interventions. These are
discrete and time limited. However, health information,
particularly those items that are stored in electronic da-
tabases exist almost timelessly and have a multitude of
uses. It may be impossible to determine all possible uses
in advance, but it is possible for individuals to define the
range of possible usages of their health information and
to specify the form of data acceptable to them.
The row headings of the health information directive
move from "most essential to most discretionary" uses,
based on Mullen and Laverey. They state:
To illustrate, the following uses of electronically stored
patient data might be placed along a continuum to reflect
ethical validity in access or use (acknowledging that the
placement of these various interests is debated by differ-
ent players), where the informing criterion is the prox-
imity of the potential user to the data generator (patient)
and their potential benefit/harm in the disclosure of in-
formation [18].BMC Medical Informatics and Decision Making (2001) 1:1 http://www.biomedcentral.com/1472-6947/1/1
The column headings illustrate the types of data from
most identifiable to most anonymous. The matrix forms
a range of options from most sensitive to least sensitive
types of data with most necessary to most discretionary
uses of information. Definitions of the column headings
immediately follow the table.
Individuals can then, as in advance directives, block out
which uses and types of data they do not wish to contrib-
ute. They may also specify the range of issues for which
they are willing to contribute data, but only with explicit
informed consent. There will be some areas that must be
blocked out because no discretion is permitted, such as
for accounting purposes.
Clearly, the health information directive will require a
significant educational effort. It is unlikely to succeed as
a stand-alone intervention. Educational programs will
be necessary to supplement the decision aid. Computer-
based educational modules or videodiscs could be em-
ployed to this end.
Discussion
The health information directive has face validity as it in-
tegrates the important elements of health information
that have been discussed in the literature. From an ethi-
cal perspective, the directive increases patient autono-
my, facilitates patient control over information, fosters
openness and transparency and respects several of the
ethical principles articulated by Kluge [19]. Whether an
Table 1: Schema for a health information directive
Personal Health Registration De-identified Aggregated
Information Information Data Statistical
Patient care (access by caregivers, such as
physicians, nurses, physiotherapists, etc., next of
kin, advocate, legal representatives)
Continuity of care between Health Care
Providers and Administrative levels
Reminders for follow-ups and screening tests,
etc.
Payment (hospital/fee for service)
Administrative management (institutional and
governmental/provincial)
Continuous Quality Improvement, peer review
Research
Epidemiological Study
Disease Registries
Hospital fund raising (mail-outs)
Deriving profit from data as a research product
Marketing
Row Headings adapted from: Ethical And Legal Issues In Electronic Health Information Systems: Report of the University of Toronto Joint Centre 
for Bioethics Working Group. 20 April 1998 Prepared by: Michelle A. Mullen, M.H.P., Ph.D. and James Lavery, M.Sc. Column Headin gs adapted from 
Saskatchewan Consultation on Privacy and Health Information. Reprinted with permission of the authors.BMC Medical Informatics and Decision Making (2001) 1:1 http://www.biomedcentral.com/1472-6947/1/1
information directive would increase or decrease author-
ization for the use of health care information remains
unknown and the topic for a future empirical study. It
may exert a differential effect by increasing the use of
some forms of information while reducing the access for
other uses. The legal status of such documents is pres-
ently unclear, but it is hoped that bringing the concept
forward for discussion may stimulate legal scholarship
on this topic. How should the directives best be distrib-
uted and administered? As the health care field becomes
increasingly based on information technology, it should
not be difficult for individuals to be able access the direc-
tives either on the Internet or on intranets. These issues,
as well as the acceptability of the directive to patients,
and the educational component that will need to accom-
pany it, will be further refined and evaluated empirically.
The empirical evaluation and refinement will consist of
the following steps. Following the process outlined by
Berry and Singer for Cancer Specific Advance directives,
key informant interviews will be conducted with stake-
holders involved in ethics, law and electronic privacy is-
sues such as Privacy Commissioners [20]. This process
will create a directive with both face and content validity.
Focus groups with lay volunteers will provide input from
the consumer perspective. Educational materials will be
developed and refined. The directive will then be evalu-
ated in a randomised study to determine whether the di-
rective can increase individual's sense of empowerment
and security over their health information.
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